CitiusTech Appoints Dhaval Shah as Acting CEO and Shyam Karunakaran as President to Lead Next Phase of Growth and Transformation
CitiusTech has appointed Dhaval Shah as Acting CEO and Shyam Karunakaran as President following the departure of Rajan Kohli. The leadership transition aims to guide the company through its next phase of growth in healthcare AI and digital transformation.
Why it matters
Leadership changes in major healthcare technology firms often signal shifts in strategic focus, particularly regarding AI adoption in the medical sector.
MUMBAI, India , Aug. 17, 2026 /PRNewswire/ -- CitiusTech , a leading digital and enterprise AI company for healthcare and life sciences organizations, today announced that Dhaval Shah, Chief Business Officer for the MedTech (HMT) and Life Sciences (HLS) markets, has been elevated to the role of Acting Chief Executive Officer, effective immediately. Shyam Karunakaran, Chief Business Officer for Healthcare Payer & Platforms (HHP & Platforms), has been elevated to the role of President, with broad responsibilities spanning enterprise strategy, markets, growth, and execution. Rajan Kohli, Chief Executive Officer, has decided to move on from his role by the end of August 2026 to pursue other opportunities.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in